UBS Group’s NewGenIvf NIVF Stock Holding History

UBS Group’s Portfolio NIVF Stock Details NIVF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32.3K	Buy	1,674 +1,668	+27,800%	+$77.2K	﹤0.01%	7842
2026 Q1	$452	Buy	+6	New	+$873	﹤0.01%	9889
2025 Q3	–	Hold	0	–	-$363	–	11075
2025 Q2	–	Hold	0	–	–	–	9851
2024 Q4	–	Hold	0	–	-$7.78K	–	10519
2024 Q3	–	Hold	0	–	–	–	7877

Other funds holding NIVF

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

UBS Group's NIVF Position: Q2 2026 in Review

UBS Group increased its NewGenIvf (NIVF) stake by 27,800% in Q2 2026, buying an estimated $77.2K and bringing the position to 1,674 shares worth $32.3K. The position accounts for ﹤0.01% of the portfolio, ranked #7842.

UBS Group first reported a position in NIVF in Q1 2026 and has held it in 2 quarters since. 5 funds tracked by Wall St. Rank hold NIVF as of Q2 2026.

UBS Group held 1,674 shares of NewGenIvf worth $32.3K as of Q2 2026.
UBS Group bought 1,668 NewGenIvf shares in Q2 2026, an estimated $77.2K.
NewGenIvf made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7842 holding.
UBS Group first reported a position in NewGenIvf in Q1 2026 and has held it in 2 quarters since.
5 funds tracked by Wall St. Rank held NewGenIvf as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.